Zhao Tantai, Li Yunqin, Tang Luosheng, Wei Xin, Zhu Xiaohua
Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha, 410011, China.
Department of Ophthalmology, the Second People's Hospital of Yunnan Province, Kunming, 650021, China.
J Huazhong Univ Sci Technolog Med Sci. 2011 Feb;31(1):142-144. doi: 10.1007/s11596-011-0166-0. Epub 2011 Feb 19.
We described clinical process of two cases of intraocular lymphoma in aspects of early diagnosis by fine needle aspiration (FNA) and biopsy and treatment by intravitreal methotrexate (MTX). Two patients were suspected to have primary intraocular lymphoma (PIOL) with geographic yellow-white infiltrates and vitreous opacity. FNA confirmed malignant intraocular lymphoma in one patient and failed in the other patient due to complication of vitreous hemorrhage. Subsequent vitreous biopsy confirmed malignant intraocular lymphoma in the other patient. Both patients were treated by intravitreal methotrexate. In case 1 the tumor had complete remission and follow-up of 12 months had not found any signs of recurrence. In case 2 the patient died of brain metastasis 22 months after the ocular biopsy. Our findings demonstrate that although cytological examination of vitrectomy specimens remains the gold standard in diagnosis of PIOL, examination of FNA and biopsy increases the reliability of early diagnosing or excluding a PIOL. Individualized intravitreal methotrexate can be used to effectively treat PIOL. More effective integrated program treating primary central nervous system lymphoma/PIOL is worthy of looking forward to.
我们从通过细针穿刺抽吸(FNA)和活检进行早期诊断以及玻璃体内注射甲氨蝶呤(MTX)治疗两个方面描述了两例眼内淋巴瘤的临床过程。两名患者疑似患有原发性眼内淋巴瘤(PIOL),表现为地图状黄白色浸润和玻璃体混浊。FNA确诊了一名患者的恶性眼内淋巴瘤,另一名患者因玻璃体出血并发症而失败。随后的玻璃体活检确诊了另一名患者的恶性眼内淋巴瘤。两名患者均接受了玻璃体内甲氨蝶呤治疗。病例1中肿瘤完全缓解,随访12个月未发现任何复发迹象。病例2中患者在眼部活检后22个月死于脑转移。我们的研究结果表明,尽管玻璃体切除标本的细胞学检查仍然是诊断PIOL的金标准,但FNA和活检检查提高了早期诊断或排除PIOL的可靠性。个体化的玻璃体内甲氨蝶呤可用于有效治疗PIOL。更有效的综合方案治疗原发性中枢神经系统淋巴瘤/PIOL值得期待。